Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,011 | -14,065 | -13,116 | -5,655 | -45,087 |
| Depreciation Amortization | 2,049 | 11 | 22 | 35 | 181 |
| Accounts payable and accrued liabilities | N/A | 1,094 | -1,958 | -65 | 443 |
| Other Working Capital | -1,203 | 618 | -2,475 | N/A | 1,004 |
| Other Operating Activity | 1,308 | 449 | 2,586 | 762 | 2,223 |
| Operating Cash Flow | $-13,857 | $-11,893 | $-14,941 | $-4,923 | $-41,236 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | -39,875 |
| PPE Investments | N/A | N/A | 8 | 1 | -565 |
| Other Investing Activity | 0 | 0 | 23,250 | 0 | -70 |
| Investing Cash Flow | $N/A | $N/A | $23,258 | $1 | $-40,510 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 2,930 | N/A |
| Common Stock Issued | 9,676 | 7,562 | 7,869 | N/A | 464 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 49 |
| Financing Cash Flow | $9,676 | $7,562 | $7,869 | $2,930 | $513 |
| Beginning Cash Position | 12,972 | 17,303 | 1,117 | 3,109 | 105,256 |
| End Cash Position | 8,791 | 12,972 | 17,303 | 1,117 | 24,023 |
| Net Cash Flow | $-4,181 | $-4,331 | $16,186 | $-1,992 | $-81,233 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,857 | -11,893 | -14,941 | -4,923 | -41,236 |
| Capital Expenditure | N/A | N/A | N/A | -9 | -565 |
| Free Cash Flow | -13,857 | -11,893 | -14,941 | -4,932 | -41,801 |